<?xml version="1.0" encoding="UTF-8"?>
<p>Biomedical devices based on chitosan (CT) were exploited for developing nanofibrous wound dressing materials [
 <xref rid="B164-pharmaceutics-13-00230" ref-type="bibr">164</xref>]. Additionally, CT is also known for its strong antibacterial activity against different fungi, bacteria, and viruses [
 <xref rid="B165-pharmaceutics-13-00230" ref-type="bibr">165</xref>,
 <xref rid="B166-pharmaceutics-13-00230" ref-type="bibr">166</xref>,
 <xref rid="B167-pharmaceutics-13-00230" ref-type="bibr">167</xref>]. However, CT viscosity, as well as the high charge of the polysaccharide chains, made difficult the electrospinning process, and the application of highly acidic and toxic solvents was required [
 <xref rid="B168-pharmaceutics-13-00230" ref-type="bibr">168</xref>]. These drawbacks can be overcome by co-spinning CT with other spun polymers, such as poly(ethylene oxide) (PEO), PCL, and PVA [
 <xref rid="B169-pharmaceutics-13-00230" ref-type="bibr">169</xref>].
</p>
